Clinical Trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for treatment of recurrent Lung Cancer .
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-11-21; most recent amendment 2026-06-15.
Status change: Not Yet Recruiting → Recruiting 2023-08-23
Trial Details
NCT Number NCT05632913
Lead Sponsor Alpha Tau Medical LTD.
Conditions Recurrent Lung Cancer, Lung Cancer
Enrollment 10 participants
Start Date 2023-07-01
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-16